Abstract
Oxaliplatin has been approved for adjuvant treatment of colorectal cancer. Toxicity induced by oxaliplatin is moderate and manageable, but some isolated cases of severe pulmonary toxicity associated to oxaliplatin have been reported. Two fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis are reported here.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Raymond E, Faivre S, Chaney S et al (2002) Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 1:227–235
André T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351
Ramanathan RK, Clark JW, Kemeny NE et al (2003) Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer. J Clin Oncol 15:2904–2911
Hausheer F, Schilsky R, Bain S et al (2006) Diagnosis, management and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 33:15–49
Anonymous (2006) Peripheral neuropathy induced by oxaliplatin-based chemotherapy. J Support Oncol 4:82–83
Patelli M, Falcone F, Poletti V (2001) Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy. Eur Respir J 1:243–245
Pasetto LM, Monfardini S (2006) Is acute dyspnea related to oxaliplatin administration? Worl J Gastroenterol 12:5907–5908
Garrido M, O’Brien A, González S et al (2007) Cryptogenetic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report. Chest 132:1997–1999
Yagüe XH, Soy E, Marino BQ et al (2006) Interstitial pneumonitis alter oxaliplatin treatment in colorrectal cancer. Clin Transl Oncol 8:624
Gagnadoux F, Roiron C, Carrie E et al (2002) Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer. Am J Clin Oncol 25:388–390
Wilcox BE, Ryu JH, Kalra S (2008) Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases. Respir Med 102:273–279
Rubbia-Brandt L, Audard V, Sartoretti P et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460–466
Kinnula VL, Vuorinen K, Ilumets H et al (2007) Thiol proteins, redox modulation and parenchymal lung disease. Curr Med Chem 14:213–222
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arévalo Lobera, S., Sagastibeltza Mariñelarena, N., Elejoste Echeberría, I. et al. Fatal pneumonitis induced by oxaliplatin. Clin Transl Oncol 10, 764–767 (2008). https://doi.org/10.1007/s12094-008-0285-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0285-7